文献速递呼吸道感染呼吸危重症与机械通气

武汉重症SARS-CoV-2肺炎患者的临床过程与结局:单中心回顾性观察研究

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.
PubMed 文献 · Lancet Respir Med · 2020-02-24

非存活者较存活者年龄更大,更易发生ARDS和接受机械通气。

要点

  • 非存活者从入ICU到死亡的中位时间仅7天。
  • 高龄、合并症及ARDS与死亡风险增加相关。

核心结论

  • 重症SARS-CoV-2肺炎患者死亡率相当高,非存活者生存时间可能在入ICU后1-2周内。
  • 年龄>65岁、合并症和ARDS的患者死亡风险增加。

研究设计与样本

  • 单中心、回顾性、观察性研究,纳入2019年12月下旬至2020年1月26日武汉金银潭医院ICU收治的52例重症SARS-CoV-2肺炎成年患者。
  • 收集人口学数据、症状、实验室值、合并症、治疗和临床结局,比较存活者与非存活者。
  • 主要结局为截至2020年2月9日的28天死亡率,次要结局包括SARS-CoV-2相关ARDS发生率和需要机械通气的患者比例。

临床怎么用

  • 对重症SARS-CoV-2肺炎患者应警惕高死亡风险,尤其是高龄、合并症和ARDS患者。
  • 需关注入ICU后1-2周内的病情变化,合理配置重症监护资源。

局限性

  • 单中心、回顾性、观察性设计,样本量较小(52例),结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: An ongoing outbreak of pneumonia associated with the severe acute respiratory coronavirus 2 (SARS-CoV-2) started in December, 2019, in Wuhan, China. Information about critically ill patients with SARS-CoV-2 infection is scarce. We aimed to describe the clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia. METHODS: In this single-centered, retrospective, observational study, we enrolled 52 critically ill adult patients with SARS-CoV-2 pneumonia who were admitted to the intensive care unit (ICU) of Wuhan Jin Yin-tan hospital (Wuhan, China) between late December, 2019, and Jan 26, 2020. Demographic data, symptoms, laboratory values, comorbidities, treatments, and clinical outcomes were all collected. Data were compared between survivors and non-survivors. The primary outcome was 28-day mortality, as of Feb 9, 2020. Secondary outcomes included incidence of SARS-CoV-2-related acute respiratory distress syndrome (ARDS) and the proportion of patients requiring mechanical ventilation. FINDINGS: Of 710 patients with SARS-CoV-2 pneumonia, 52 critically ill adult patients were included. The mean age of the 52 patients was 59·7 (SD 13·3) years, 35 (67%) were men, 21 (40%) had chronic illness, 51 (98%) had fever. 32 (61·5%) patients had died at 28 days, and the median duration from admission to the intensive care unit (ICU) to death was 7 (IQR 3-11) days for non-survivors. Compared with survivors, non-survivors were older (64·6 years [11·2] vs 51·9 years [12·9]), more likely to develop ARDS (26 [81%] patients vs 9 [45%] patients), and more likely to receive mechanical ventilation (30 [94%] patients vs 7 [35%] patients), either invasively or non-invasively. Most patients had organ function damage, including 35 (67%) with ARDS, 15 (29%) with acute kidney injury, 12 (23%) with cardiac injury, 15 (29%) with liver dysfunction, and one (2%) with pneumothorax. 37 (71%) patients required mechanical ventilation. Hospital-acquired infection occurred in seven (13·5%) patients. INTERPRETATION: The mortality of critically ill patients with SARS-CoV-2 pneumonia is considerable. The survival time of the non-survivors is likely to be within 1-2 weeks after ICU admission. Older patients (>65 years) with comorbidities and ARDS are at increased risk of death. The severity of SARS-CoV-2 pneumonia poses great strain on critical care resources in hospitals, especially if they are not adequately staffed or resourced. FUNDING: None.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020. PMID: 32105632. doi:10.1016/S2213-2600(20)30079-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。